Skip to main content
Contact Us
Subscribe
E-Edition
79°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
159.62
-7.67 (-4.58%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
59
60
Next >
3 Top Dividend Kings to Buy for the Long Haul
November 30, 2022
Dividend stocks are an easy option to boost income.
Via
The Motley Fool
The Most Popular Stocks Millennial And Gen-Z Are Investing In
November 30, 2022
Over the next 25 years Millennials and Gen Z will inherit nearly $70 trillion from their grandparents and parents. But many of them are not waiting to start investing in stocks. So what stocks are they...
Via
Talk Markets
3 Reasons Pfizer Stock Will Crush the Broader Market in 2023
November 29, 2022
Pfizer's revenue growth is far from over.
Via
The Motley Fool
8 Dividend Aristocrats to Buy Now for a Lifetime of Passive Income
November 27, 2022
Dividend stocks are a great way to protect against a downturn and these are the cream of the crop.
Via
The Motley Fool
Better Dividend Stock: AbbVie or Viatris?
November 26, 2022
These pharmaceutical companies are profitable and offer above-average dividends.
Via
The Motley Fool
Where AbbVie Stands With Analysts
November 18, 2022
Via
Benzinga
Credit Suisse Says AbbVie's Humira Patent Cliff Could Provide Momentum to Boost Growth
November 18, 2022
Via
Benzinga
Analyst Ratings for AbbVie
November 18, 2022
Via
Benzinga
3 Dividend Stocks to Hold Forever
November 26, 2022
These businesses -- and dividends -- are built to last.
Via
The Motley Fool
Is Now the Time for Income Investors to Buy This Big Pharma Stock?
November 24, 2022
This drugmaker is among the most dominant pharmaceutical companies in the world.
Via
The Motley Fool
Could an Investment in AbbVie Give You $10,000 in Annual Dividend Income by Retirement?
November 23, 2022
This is a stock that rewards long-term investors through continual dividend increases.
Via
The Motley Fool
Want $10,000 in Annual Dividend Income by Retirement? Here's How Much You Should Invest in AbbVie Today.
November 23, 2022
This is a stock that rewards long-term investors through continual dividend increases.
Via
The Motley Fool
2 Safe Dividend Stocks to Buy Hand Over Fist
November 23, 2022
These businesses may not be "exciting," but that's not such a bad thing right now.
Via
The Motley Fool
AbbVie Boosts Its Dividend: Is the Dividend King a Buy?
November 23, 2022
Shares of the pharmaceutical stock have left the S&P 500 index in the dust so far this year.
Via
The Motley Fool
What 8 Analyst Ratings Have To Say About AbbVie
November 18, 2022
Via
Benzinga
What Does AbbVie's Debt Look Like?
November 18, 2022
Over the past three months, shares of AbbVie's Inc. (NYSE:ABBV) rose by 11.27%. Before having a look at the importance of debt, let's look at how much debt AbbVie's has.
Via
Benzinga
AbbVie's Migraine Treatment Scores Canadian Approval
November 16, 2022
Via
Benzinga
AbbVie Finalizes To Pay Around $2.4B In Settlement Against US Opioid Lawsuits
November 22, 2022
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 22, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
2 Reasons to Buy AbbVie Stock and 1 Reason to Sell
November 22, 2022
The pharmaceutical company's golden goose is about to stop laying golden eggs, but that won't be a permanent problem.
Via
The Motley Fool
Want Passive Income in 2023? Buy These Dividend Kings
November 22, 2022
These stocks offer you a gift: recurrent income just for owning them.
Via
The Motley Fool
3 Top Dividend Stocks to Buy Now With Yields of 3.4% or More
November 21, 2022
These stocks offer attractive yields now, and investors can look forward to lots of payout raises.
Via
The Motley Fool
Exicure Flags Bankruptcy Concerns, Shares Fall
November 15, 2022
Via
Benzinga
If You Invested $5,000 In InMode Stock In 2020, Here's How Much Money You'd Have Today
November 20, 2022
There's even more growth on the way -- and likely soon.
Via
The Motley Fool
2 Breakout Growth Stocks to Buy for the Long Haul
November 19, 2022
These two Russell 1000 members know how to grow revenue.
Via
The Motley Fool
MarketBeat: Week in Review 11/14 – 11/18
November 19, 2022
This week, investors digested negative news from the retail sector and the Fed and next week's abbreviated trading week won't bring much new news.
Via
MarketBeat
Topics
Economy
Workforce
Exposures
Economy
Interest Rates
Layoff
10 Health Care Stocks Whale Activity In Today's Session
November 18, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Upgrades
Via
Benzinga
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
November 16, 2022
Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry.
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID
November 17, 2022
Palm Beach, FL – November 17, 2022 – FinancialNewsMedia.com News Commentary – Since the beginning of the pandemic, the critical effort of researchers is to understand how coronavirus damages the body....
Via
FinancialNewsMedia
Exposures
COVID-19
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
59
60
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.